Detection of Non-Alcoholic Fatty Liver Disease with Non-invasive Tools in Turkish People Living with HIV and with Apparently Normal Liver Function

Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?

(2021) Athanasios-Dimitrios Bakasis et al.   Cells

Prevalence, predictors and severity of lean non-alcoholic fatty liver disease in HIV-infected patients

(2020) Adriana Cervo et al.   CLINICAL INFECTIOUS DISEASES

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

(2020) Kassem Bourgi et al.   Journal of the International AIDS Society

Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement

(2020) Richard G. Barr et al.   RADIOLOGY

MR elastography of liver: current status and future perspectives

(2020) Ilkay S. Idilman et al.   Abdominal Radiology

NASH in HIV

(2020) Adriana Cervo et al.   Current HIV/AIDS Reports

Accuracy of imaging methods for steatohepatitis diagnosis in non‐alcoholic fatty liver disease patients: A systematic review

(2019) Giulia Besutti et al.   LIVER INTERNATIONAL

Diagnostic accuracy of noninvasive markers of steatosis, NASH and liver fibrosis in HIV-monoinfected individuals at-risk of non-alcoholic fatty liver disease (NAFLD)

(2018) Maud Lemoine et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Non-alcoholic fatty liver disease – A global public health perspective

(2018) Zobair M. Younossi   JOURNAL OF HEPATOLOGY

Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis

(2017) Guangqin Xiao et al.   HEPATOLOGY

Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging

(2017) Jens-Peter Kühn et al.   RADIOLOGY

Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection

(2016) Rosa Lombardi et al.   DIGESTIVE AND LIVER DISEASE

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

(2016) Elena Buzzetti et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy

(2015) Caryn G. Morse et al.   AIDS

Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy

(2015) C. G. Morse et al.   CLINICAL INFECTIOUS DISEASES

The “Saltin-Grimby Physical Activity Level Scale” and its application to health research

(2015) G. Grimby et al.   SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS

Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study

(2014) I. Vodkin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease

(2014) Ying Ding et al.   EUROPEAN RADIOLOGY

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

(2014) Colette J Smith et al.   LANCET

A position statement on NAFLD/NASH based on the EASL 2009 special conference

(2010) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE